Analysis of a Real-World Progression Variable and Related Endpoints for Patients with Five Different Cancer Types.
Aracelis Z TorresNathan C NussbaumChristina M ParrinelloAriel B BourlaBryan E BowserSamuel WagnerDavid C TabanoDaniel GeorgeAriel Bulua BourlaPublished in: Advances in therapy (2022)
Derivation of a rwP variable from EHR documentation is feasible and reliable across the five solid tumors. Endpoint analyses show that rwP produces clinically meaningful information.